Recombinant and synthetic nucleic acid research must be done in accordance with the current edition of the NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules. Infectious Agent research must be done following the guidelines issued in the NIH/CDC publication Biosafety in Microbiological and Biomedical Laboratories. Significant issues of non-compliance are reportable to the Office of Science Policy at the National Institutes of Health and to the relevant funding agency.
The Institutional Biosafety Committees (IBC) has provided the following methods that may be used to report any deficiency or non-compliance with the use of biohazardous materials at this Institution:
Reported issues will be investigated and solutions determined on a case-by-case basis. Verification will be provided to the complainant (if known) that the report has been received and the issue is under investigation. After a report is received, if it is determined to be an issue of non-compliance, the resolution will be reported in the IBC’s Minutes.